As part of our healthcare sector focus, Thierry Heles takes a closer looks at Johnson & Johnson, and their rebranded Johnson & Johnson Innovation division.

Drug developer Ergomed acquires Leicester spinout Haemostatix, which is developing a blood clotting peptide sequence, for $11.5m upfront and a potential future payment of $29m.

Sector report: Healthcare

The concierge care provider previously raised money from healthcare corporates to extend its reach in Minnesota and other regions.

Clinical genome interpretation technology producer Omicia has secured capital from investors including Roche, Ping An and UPMC to accelerate product development.

Biovotion has secured a first close for its series A round, backed by Swiss Re and STMicroelectronics.

GE-backed healthcare IT company Jiff has secured an additional $17.7m for its series C round, which achieved a first close at $23.5m in May last year.

Commercialisation bootcamp supports UCD researchers as they learn how to bring their ideas, such as a formaldehyde replacement and a rapid, low-cost multiple sclerosis test, to market.

Asia-based corporates Ping An, Fosun Pharmaceutical and SK Group have participated in a series D round for the biotechnology company.